Luminal A, luminal B, HER-2 overexpressing, and TNBC subtypes are the main classifications for breast cancer based on the expression of particular biomarkers like Ki67, HER-2, progesterone receptor (PR), estrogen receptor (ER) (2). This evidence concerns the gene ESR1 and breast carcinoma.